[Determination of minimum effective concentration and proposed dosage regimen of pyronaridine in the treatment of malaria].
Feng
Z
Z
Wang
C Y
CY
Qiu
C P
CP
Wu
Z F
ZF
Gao
D Q
DQ
Liu
R J
RJ
D000818:Animals; D000962:Antimalarials / Q000008:administration & dosage* / Q000493:pharmacokinetics; D006801:Humans; D008288:Malaria / Q000188:drug therapy*; D009287:Naphthyridines / Q000008:administration & dosage* / Q000493:pharmacokinetics; D010963:Plasmodium falciparum; D011817:Rabbits
D000962:Antimalarials; D009287:Naphthyridines; C027871:pyronaridine